Literature DB >> 21079430

Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions.

Haileyesus Getahun1, Reuben Granich, Delphine Sculier, Christian Gunneberg, Leopold Blanc, Paul Nunn, Mario Raviglione.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21079430     DOI： 10.1097/01.aids.0000391023.03037.1f

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  60 in total

1.  Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped.

Authors:  Faiz Ahmad Khan; Sabine Verkuijl; Andrew Parrish; Fadzai Chikwava; Raphael Ntumy; Wafaa El-Sadr; Andrea A Howard
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

Review 2.  Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.

Authors:  Nicole Salazar-Austin; David W Dowdy; Richard E Chaisson; Jonathan E Golub
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

3.  Dotting the Three I's for collaborative TB-HIV activities: evaluation of a pilot programme in Kathmandu, Nepal.

Authors:  S K Sah; S K Sahu; B Lamichhane; G K Bhatta; K B Bhandari; P Owiti; S S Majumdar
Journal:  Public Health Action       Date:  2016-09-21

4.  Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.

Authors:  Khai Hoan Tram; Florence Mwangwa; Gabriel Chamie; Mucunguzi Atukunda; Asiphas Owaraganise; James Ayieko; Vivek Jain; Tamara D Clark; Dalsone Kwarisiima; Maya L Petersen; Moses R Kamya; Edwin D Charlebois; Diane V Havlir; Carina Marquez
Journal:  AIDS Care       Date:  2019-06-10

5.  Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda.

Authors:  Monika Roy; Winnie Muyindike; Tara Vijayan; Michael Kanyesigye; Mwebesa Bwana; Megan Wenger; Jeffrey Martin; Elvin Geng
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

Review 6.  Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.

Authors:  Christopher Akolo; Florence Bada; Evaezi Okpokoro; Ogochukwu Nwanne; Sharon Iziduh; Eno Usoroh; Taofeekat Ali; Vivian Ibeziako; Olanrewaju Oladimeji; Michael Odo
Journal:  World J Virol       Date:  2015-05-12

7.  Priorities among HIV-positive individuals for tuberculosis preventive therapies.

Authors:  H-Y Kim; C F Hanrahan; D W Dowdy; N A Martinson; J E Golub; J F P Bridges
Journal:  Int J Tuberc Lung Dis       Date:  2020-04-01       Impact factor: 2.373

8.  Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia.

Authors:  J Lai; Z Dememew; D Jerene; A Abashawl; B Feleke; A M Teklu; A Ruff
Journal:  Int J Tuberc Lung Dis       Date:  2019-03-01       Impact factor: 2.373

9.  Integration of TB-HIV services at an ANC facility in Frances Baard District, Northern Cape, South Africa.

Authors:  J A Peters; C Heunis; G Kigozi; T Osoba; M van der Walt
Journal:  Public Health Action       Date:  2015-03-21

10.  IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence.

Authors:  J Ousley; K P Soe; N T T Kyaw; R Anicete; P E Mon; H Lwin; T Win; S Cristofani; A Telnov; M Fernandez; I Ciglenecki
Journal:  Public Health Action       Date:  2018-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.